Abstract
Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)— Transplant Outcomes Post HMA Therapy in a Large International Patient Cohort
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have